Related references
Note: Only part of the references are listed.Use of Chest Radiography Examination as a Probe for Pneumococcal Conjugate Vaccine Impact on Lower Respiratory Tract Infections in Young Children
Shalom Ben-Shimol et al.
CLINICAL INFECTIOUS DISEASES (2020)
Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States
Andrew D. Wiese et al.
EXPERT REVIEW OF VACCINES (2019)
Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children
Naim Ouldali et al.
JAMA PEDIATRICS (2019)
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study
Shamez N. Ladhani et al.
LANCET INFECTIOUS DISEASES (2018)
Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017
M. Teresa Aguado et al.
VACCINE (2018)
Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil
Maria-Cristina C. Brandileone et al.
VACCINE (2018)
Effectiveness of different vaccine schedules for heptavalent and 13-valent conjugate vaccines against pneumococcal disease in the Community of Madrid
P. Latasa et al.
VACCINE (2017)
Impact of 1.3-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children
Jesus Ruiz-Contreras et al.
VACCINE (2017)
Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain
Jordi Camara et al.
PLOS ONE (2017)
Relating Pneumococcal Carriage Among Children to Disease Rates Among Adults Before and After the Introduction of Conjugate Vaccines
Daniel M. Weinberger et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project)
I. Rivero-Calle et al.
BMC INFECTIOUS DISEASES (2016)
VACCINE FAILURES IN PATIENTS PROPERLY VACCINATED WITH 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN CATALONIA, A REGION WITH LOW VACCINATION COVERAGE
Fernando Moraga-Llop et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2016)
Beyond efficacy: The full public health impact of vaccines
Mitra Saadatian-Elahi et al.
VACCINE (2016)
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
Matthew R. Moore et al.
LANCET INFECTIOUS DISEASES (2015)
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
M. J. M. Bonten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years
David Greenberg et al.
VACCINE (2015)
Early Impact of 13-Valent Pneumococcal Conjugate Vaccine on Community-Acquired Pneumonia in Children
F. Angoulvant et al.
CLINICAL INFECTIOUS DISEASES (2014)
Pneumococcal infection in adults: burden of disease
J. J. C. Drijkoningen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Spread of Streptococcus pneumoniae Serotype 8-ST63 Multidrug-Resistant Recombinant Clone, Spain
Carmen Ardanuy et al.
EMERGING INFECTIOUS DISEASES (2014)
Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: Review of evidence on indirect effects
Stephanie M. Davis et al.
VACCINE (2013)
Influence of Pneumococcal Vaccines and Respiratory Syncytial Virus on Alveolar Pneumonia, Israel
Daniel M. Weinberger et al.
EMERGING INFECTIOUS DISEASES (2013)
Dynamics of pneumococcal nasopharyngeal carriage in healthy children attending a day care center in northern Spain. Influence of detection techniques on the results
Maria Ercibengoa et al.
BMC INFECTIOUS DISEASES (2012)
The fundamental link between pneumococcal carriage and disease
Birgit Simell et al.
EXPERT REVIEW OF VACCINES (2012)
Trends of invasive serotype 6C pneumococci in Spain: emergence of a new lineage
Dora Rolo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Serotype replacement in disease after pneumococcal vaccination
Daniel M. Weinberger et al.
LANCET (2011)
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study
Elizabeth Miller et al.
LANCET INFECTIOUS DISEASES (2011)
The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007)
Ruth Gil-Prieto et al.
VACCINE (2011)
Impact of Pneumococcal Conjugate Vaccination of Infants on Pneumonia and Influenza Hospitalization and Mortality in All Age Groups in the United States
Lone Simonsen et al.
MBIO (2011)
Reduction in Hospitalizations for Pneumonia Associated With the Introduction of a Pneumococcal Conjugate Vaccination Schedule Without a Booster Dose in Australia
Andrew Jardine et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997-2008
Elizabeth Koshy et al.
THORAX (2010)
Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine
Carmen Munoz-Almagro et al.
CLINICAL INFECTIOUS DISEASES (2008)
Invasive pneumococcal disease among children in a health district of Barcelona:: early impact of pneumococcal conjugate vaccine
E. Calbo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Impact of PCV7 on invasive pneumococcal disease among children younger than 5 years: A population-based study
RR Ramani et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2004)
Share Paper
